Antipsychotics and Lorazepam During Delirium: Are We Harming Older Patients? A Real-Life Data Study
Open Access
- 9 November 2020
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 38 (1) , 53-62
Abstract
Background Delirium affects approximately one out of three older hospitalized patients and is associated with poor clinical outcomes. Approaches used to manage delirium consist of non-pharmacological and pharmacological interventions. Antipsychotics and lorazepam are commonly used to treat symptoms of delirium, but conflicting data exist on the effect of these drugs on the outcomes of delirium. Objective The aim of this study was to investigate whether the use of antipsychotics, with or without lorazepam, increases the risk of prolonged hospital stay, post-discharge institutionalization, and in-hospital mortality in older patients with delirium. Methods In this retrospective chart review study, we included acutely ill patients aged ≥ 65 years who were admitted to a geriatric ward and diagnosed with delirium. Patients were stratified into three groups based on whether or not they received antipsychotics and lorazepam to manage delirium: (0) no antipsychotics; (1) antipsychotics only; and (2) antipsychotics plus lorazepam. Length of hospital stay (LOS) and frequencies of post-discharge institutionalization and in-hospital mortality were compared. Results In total, 212 patients with delirium were included (mean age 81.9 ± 5.6 years); 40 did not receive antipsychotics (18.9%), 123 received antipsychotics only (58.0%) and 49 received antipsychotics and lorazepam (23.1%). There was a trend to a longer LOS in patients who received both antipsychotics and lorazepam (median LOS group 0 = 8.0 days, group 1 = 10.0 days, and group 2 = 12.0 days). Furthermore, trends to a higher incidence of post-discharge institutionalization and in-hospital mortality were observed in patients who received both treatments (institutionalization group 0 = 45.0%, group 1 = 59.3%, group 2 = 81.6%; and in-hospital mortality group 0 = 7.5%, group 1 = 10.6%, group 2 = 16.3%). Conclusion The use of antipsychotics, with or without lorazepam, during delirium is associated with increased risks of poor outcomes. These findings suggest that clinicians should be cautious about routine prescribing of these drugs to older patients with delirium. Further investigation is needed to clarify this association.Keywords
Funding Information
- University Medical Center Rotterdam
This publication has 39 references indexed in Scilit:
- Development and validation of a decision tree early warning score based on routine laboratory test results for the discrimination of hospital mortality in emergency medical admissionsResuscitation, 2013
- Consensus and variations in opinions on delirium care: a survey of European delirium specialistsInternational Psychogeriatrics, 2013
- Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care UnitCritical Care Medicine, 2013
- Assessing severity of delirium by the delirium observation screening scaleInternational Journal of Geriatric Psychiatry, 2011
- Use of antipsychotic medications for the management of delirium: an audit of current practice in the acute care settingInternational Psychogeriatrics, 2008
- The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older PersonsArchives of internal medicine (1960), 2008
- Antipsychotics for delirium2007
- Occurrence and outcome of delirium in medical in-patients: a systematic literature reviewAge and Ageing, 2006
- The Delirium Observation Screening Scale: A Screening Instrument for DeliriumResearch and Theory for Nursing Practice, 2003
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987